We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-0.76%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$11.4B
AUM Growth
+$282M
Cap. Flow
+$504M
Cap. Flow %
4.41%
Top 10 Hldgs %
13.8%
Holding
2,664
New
339
Increased
765
Reduced
639
Closed
146

Sector Composition

Rank Sector Weight
1 Technology 15.18%
2 Healthcare 13.66%
3 Industrials 12.88%
4 Financials 10.57%
5 Energy 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOT
1176
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$165K ﹤0.01%
1,993
APAM icon
1177
Artisan Partners
APAM
$2.93B
$163K ﹤0.01%
3,153
+519
+20% +$28K
BR icon
1178
Broadridge
BR
$18.4B
$163K ﹤0.01%
3,935
-747
-16% -$31K
HNI icon
1179
HNI Corp
HNI
$3.2B
$162K ﹤0.01%
4,521
CVA
1180
DELISTED
Covanta Holding Corporation
CVA
$162K ﹤0.01%
7,660
CHH icon
1181
Choice Hotels
CHH
$5.22B
$161K ﹤0.01%
3,125
-40
-1% -$2.02K
PVH icon
1182
PVH
PVH
$3.98B
$160K ﹤0.01%
1,326
+16
+1% +$1.88K
NS
1183
DELISTED
NuStar Energy L.P.
NS
$159K ﹤0.01%
2,412
BTI icon
1184
British American Tobacco
BTI
$134B
$158K ﹤0.01%
2,806
+2,054
+273% +$121K
IONS icon
1185
Ionis Pharmaceuticals
IONS
$9.04B
$158K ﹤0.01%
4,085
-3,623
-47% -$128K
TIF
1186
DELISTED
Tiffany & Co.
TIF
$158K ﹤0.01%
1,650
+1,600
+3,200% +$160K
WBK
1187
DELISTED
Westpac Banking Corporation
WBK
$157K ﹤0.01%
5,630
+4,062
+259% +$128K
ALNY icon
1188
Alnylam Pharmaceuticals
ALNY
$38.3B
$156K ﹤0.01%
2,000
-400
-17% -$25.8K
E icon
1189
ENI
E
$72.9B
$156K ﹤0.01%
3,329
+2,436
+273% +$123K
FBIN icon
1190
Fortune Brands Innovations
FBIN
$6.15B
$156K ﹤0.01%
4,462
XEL icon
1191
Xcel Energy
XEL
$50.8B
$156K ﹤0.01%
5,177
CAJ
1192
DELISTED
Canon, Inc.
CAJ
$156K ﹤0.01%
4,819
+4,437
+1,162% +$147K
SWY
1193
DELISTED
SAFEWAY INC
SWY
$156K ﹤0.01%
4,577
-10,494
-70% -$363K
ICLR icon
1194
Icon
ICLR
$13.9B
$154K ﹤0.01%
2,700
RF icon
1195
Regions Financial
RF
$26.5B
$153K ﹤0.01%
15,332
-146,992
-91% -$1.5M
ORAN
1196
DELISTED
Orange
ORAN
$153K ﹤0.01%
10,531
+8,981
+579% +$136K
JPM.PRB.CL
1197
DELISTED
JPMorgan Chase & Co.
JPM.PRB.CL
$153K ﹤0.01%
6,000
CBI
1198
DELISTED
Chicago Bridge & Iron Nv
CBI
$153K ﹤0.01%
2,667
-94
-3% -$5.93K
ZION icon
1199
Zions Bancorporation
ZION
$10.1B
$151K ﹤0.01%
5,241
+1,385
+36% +$40.2K
SLXP
1200
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$151K ﹤0.01%
975
+218
+29% +$31.6K

Similar funds

Glenmede Trust's Q3 2014 Portfolio in Review

As of Q3 2014, Glenmede Trust held 2,664 positions worth $11.4B, up 2.5% from $11.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $504M of net new capital in Q3 2014, opening 339 new positions and adding to 765 existing holdings. Its largest new stake was Acadia Healthcare: 426,301 shares worth $20.7M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Spirit Airlines, Inc., an estimated $22.2M trimmed.

  • Glenmede Trust's largest Q3 2014 buy was Acadia Healthcare: 426,301 shares worth $20.7M.
  • Glenmede Trust added most to Brunswick in Q3 2014, an estimated $24.1M increase.
  • Glenmede Trust's biggest Q3 2014 reduction was Spirit Airlines, Inc., cutting an estimated $22.2M.
  • Glenmede Trust fully exited Unisys in Q3 2014, selling an estimated $13.5M.
  • Glenmede Trust's ten largest holdings make up 14% of its $11.4B portfolio in Q3 2014.
  • Glenmede Trust opened 339 new positions and closed 146 in Q3 2014.
  • Glenmede Trust's portfolio value rose 2.5% quarter-over-quarter to $11.4B.

Based on Glenmede Trust's 13F filing for Q3 2014, filed 14 Nov 2014.